Vitality Biopharma Adopts New Name – Malachite Innovations, Inc.
12 oct. 2021 09h00 HE
|
Malachite Innovations, Inc.
CLEVELAND, Ohio, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. has changed its name to MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (pronounced “mal-a-kite”) following a corporate...
Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eligibility
02 sept. 2021 23h45 HE
|
Vitality Biopharma, Inc
CLEVELAND, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTC Mkts: VBIO) (“Vitality” or the “Company”), an innovation-driven drug development company dedicated to unlocking the...
Vitality Biopharma Enters Into $5 Million Equity Line Financing Relationship With Institutional Investor
20 août 2021 09h00 HE
|
Vitality Biopharma, Inc
CLEVELAND, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (VBIO) (“Vitality” or the “Company”), an innovation-driven drug development company dedicated to unlocking the therapeutic...
FDA Grants Vitality Biopharma Orphan Drug Designation for VBX-100 Prodrug
10 août 2021 09h00 HE
|
Vitality Biopharma, Inc
CLEVELAND, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTC: VBIO) (“Vitality” or the “Company”), an innovation-driven drug development company dedicated to unlocking the therapeutic...
Vitality Biopharma Retains DelMorgan & Co. to Explore Strategic Alternatives
25 sept. 2020 09h00 HE
|
Vitality Biopharma, Inc
CLEVELAND, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”), a drug development company dedicated to unlocking the unique therapeutic powers of...
Vitality Biopharma Board Update
27 avr. 2020 16h52 HE
|
Vitality Biopharma, Inc
CLEVELAND, April 27, 2020 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (Ticker: VBIO) (“Vitality Biopharma,” “Vitality,” or the “Company”), a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Welcomes New Executive Management Team
14 mai 2019 09h00 HE
|
Vitality Biopharma, Inc
– Appointment of Current Director Michael Cavanaugh as Interim Chief Executive Officer –– Promotion of Current Controller and Counsel Richard McKilligan to Chief Financial Officer – LOS ANGELES, May ...
Vitality Biopharma Co-Founder Dr. Avtar Dhillon Resigns from Board of Directors
25 avr. 2019 12h00 HE
|
Vitality Biopharma, Inc
LOS ANGELES, April 25, 2019 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (Ticker: VBIO) (“Vitality Biopharma,” “Vitality,” or the “Company”), a corporation dedicated to the development of...
Vitality Biopharma Appoints Former Ohio Governor Richard F. Celeste to Board
24 janv. 2019 15h56 HE
|
Vitality Biopharma, Inc
LOS ANGELES, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (Ticker: VBIO) (“Vitality Biopharma,” “Vitality,” or the “Company”), a corporation dedicated to the development of cannabinoid...
Vitality Biopharma to Present at the 11th Annual LD Micro Main Event
03 déc. 2018 08h00 HE
|
Vitality Biopharma, Inc
LOS ANGELES, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (Ticker: VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug...